Latest Capital Raise News

Syntara Limited has raised A$10 million through a two-tranche placement and share purchase plan, backing its Phase 2b myelofibrosis trial and multiple clinical readouts following positive FDA feedback.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.

PhosCo Ltd has reported rock chip assays up to 21.3% copper and 100 g/t silver from the King’s Eye prospect within its Simitu Project in northern Tunisia, alongside geophysical evidence of sulphide mineralisation at depth warranting immediate follow-up.

Anax Metals’ updated DFS for Whim Creek reveals a 113% surge in free cash flow to A$723 million, underpinned by a decade-long mine life and rapid payback. The company’s $10 million capital raise strengthens its balance sheet following full repayment of a $3.5 million loan.

Caprice Resources has confirmed significant extensions of high-grade gold mineralisation at its Island Gold Project, backed by a $12.74 million capital raise and a new multi-rig drilling campaign.

Dundas Minerals has secured $2.5 million to fund extensive drilling across its Western Australian gold portfolio, exercised its option to acquire the Rockland mining lease, and expanded the Romano project with a new exploration licence application near Gruyere.

Horizon Gold has reported strong high-grade gold intercepts from drilling at its Omega and Kingfisher prospects in Western Australia, extending mineralisation and advancing its feasibility study on a 2.3 million ounce resource base.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.

Alma Metals has launched an extensive drilling campaign at its Briggs Copper Project in Queensland, aiming to upgrade and grow its 2 million tonne copper resource ahead of pre-feasibility studies.

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.

Mt Malcolm Mines has delivered a maiden Mineral Resource Estimate of 13,200 ounces across Golden Crown and Dumbarton, while advancing a study on refurbishing a 500,000 tpa CIP plant and preparing for follow-up drilling and funding.

Peak Processing reported its first positive EBITDA month in March 2026, driven by operational efficiencies and strong production growth. The company upgraded its Q4 production forecast and expanded key customer contracts, signaling a turning point after a challenging period.